Evaluation of antimicrobial and surgical treatment for MRSA (methicillin-resistant Staphylococcus aureus) endocarditis.

Evaluation of antimicrobial and surgical treatment for MRSA (methicillin-resistant Staphylococcus aureus) endocarditis. - Evaluation of antimicrobial and surgical treatment for MRSA (methicillin-resistant Staphylococcus aureus) endocarditis.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051931

Enrollment

Registered

2023-08-17

Start date

2019-03-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infective endocarditis (IE) due to MRSA

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with a definite diagnosis of MRSA-IE from January 2015 to April 2019 were included.

Exclusion criteria

Exclusion criteria: -Patients under the age of 16. -Patients with Healed IE.

Design outcomes

Primary

Measure	Time frame
30-day and in-hospital mortality	—

Countries

Japan

Contacts

Public ContactNatsuki Shinya

Saitama Medical University International Medical Center Infection Control Center

ns92671@5931.saitama-med.ac.jp0429844111

Outcome results